CRISPR startup Arbor Biotechnologies raises $73.9M as it nears first trial

Arbor Biotechnologies, a startup founded by CRISPR pioneer Feng Zhang nine years ago, has closed a $73.9 million Series C financing to bring its first therapy into clinical trials — a treatment that could help prevent ...

Mar 18, 2025 - 11:30
 0
CRISPR startup Arbor Biotechnologies raises $73.9M as it nears first trial
Arbor Biotechnologies, a startup founded by CRISPR pioneer Feng Zhang nine years ago, has closed a $73.9 million Series C financing to bring its first therapy into clinical trials — a treatment that could help prevent ...